Medicare Advantage Rates for 2027: Key Changes and Industry Reactions
Insurance brokers are adjusting to recent developments in Medicare Advantage (MA) rates for 2027, as the Centers for Medicare & Medicaid Services (CMS) have revised their initial proposal. The finalized policy outlines a 2.48% increase, a notable change from the initially proposed 0.09%, representing approximately $13 billion in additional funding for plans. CMS stated that this adjustment reflects the underlying cost growth, potential influences of 2026 star ratings on bonus payments, and modifications in risk adjustment methodologies.
During a press call, Chris Klomp, the director of Medicare and chief counselor for the Department of Health and Human Services, emphasized that the rule's objective is to balance immediate program challenges while supporting the long-term viability of MA. Although the agency increased the rates, it continues to focus on insurer practices such as upcoding that could unfairly enhance profits within the program.
The proposal had drawn a strong response from the industry, which argued that static rates were unsustainable amid rising healthcare costs and utilization. Payers had expressed concern that flat rates could necessitate benefit reductions or market withdrawals. The revised rate proposal, however, brought a positive response from the market, with insurance companies experiencing an increase in their stock values following the announcement.
The more significant rate hike is attributed to the postponement of proposed risk adjustment changes that were part of version 28 (V28) revisions. Klomp noted that allowing these changes to settle into place will provide time for adjustments and could encourage participation in value-based care models, a priority for CMS.
The insurance lobbying group, AHIP, acknowledged the recent policy updates, committing to maintaining affordability despite escalating medical expenses. AMGA, a leading provider organization, expressed dissatisfaction with the rate increase, arguing it does not reflect the actual costs of healthcare service delivery. They indicated concerns about potential plan cuts and the exclusion of diagnoses from audio-only telehealth visits affecting risk adjustment.
AMGA President and CEO Jerry Penso highlighted the need for sustained investment to manage the rising costs of delivering high-quality care and expressed a willingness to collaborate with CMS to ensure Medicare Advantage's long-term sustainability.